Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTDesign and Therapeutic Application of Matrix Metalloproteinase InhibitorsMark Whittaker, Christopher D. Floyd, Peter Brown, and Andrew J. H. GearingView Author Information Departments of Medicinal Chemistry, Biology, and Clinical Research, British Biotech Pharmaceuticals Limited, Oxford, U.K. Cite this: Chem. Rev. 1999, 99, 9, 2735–2776Publication Date (Web):September 8, 1999Publication History Received26 April 1999Revised22 June 1999Published online8 September 1999Published inissue 8 September 1999https://pubs.acs.org/doi/10.1021/cr9804543https://doi.org/10.1021/cr9804543research-articleACS PublicationsCopyright © 1999 American Chemical SocietyRequest reuse permissionsArticle Views4556Altmetric-Citations820LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Cancer,Inhibition,Inhibitors,Peptides and proteins,Substituents Get e-Alerts